ORIGINAL RESEARCH

Antioxidant effects of the synthetic thyronamine analogue in experimental cerebral ischemia

Filimonov DA1, Eresko AB2, Raksha EV2, Trubnikova NN1, Ischenko RV1, Tereschenko DA1, Kisilenko IA1, Nosova IN1
About authors

1 V.K. Gusak Institute of Emergency and Reconstructive Surgery, Donetsk, Russia

2 Joint Institute for Nuclear Research, Dubna, Russia

Correspondence should be addressed: Dmitry A. Filimonov
Leninsky Prospekt, 47, Donetsk, 283045, Russia; ur.xednay@umnd.oruen

About paper

Funding: the study was carried out within the framework of the state assignment of the Ministry of Health of the Russian Federation № 1023042500162-83.1.4;3.2.25 (2023–2025).

Author contribution: Filimonov DA — core concept, general management, constructing the statistical model, data processing; Eresko AB, Raksha EV — data acquisition, literature review, Т0АМ synthetic analogue preparation and spectroscopic analysis; Trubnikova NN — design of the experiment on ischemia simulation, experimental procedure, data acquisition, manuscript writing; Ischenko RV — general management, data acquisition, manuscript editing; Tereschenko DA — biochemical tests, data acquisition, manuscript draft editing; Kisilenko IA — animal experiments, manuscript writing and editing; Nosova IN — data acquisition and processing.

Compliance with ethical standards: the study was approved by the Ethics Committee of the V.K. Gusak Institute of Emergency and Reconstructive Surgery (protocol No 3 dated 23 November 2023).

Received: 2024-01-04 Accepted: 2024-02-04 Published online: 2024-03-22
|

The oxidative stress associated with ischemic stroke is a major factor damaging the nervous tissue. Thyroid hormones have a significant effect on the body’s redox status, however, the impact of their derivatives, thyronamines, considered as potential neuroprotectors, on the characteristics of lipid peroxidation (LP) is not clearly understood. The study was aimed to assess the impact of the Т0АМ thyronamine synthetic analogue on the main LP indicators in the model of acute cerebral ischemia. Permanent ligation of the right common carotid artery was performed to simulate acute cerebral ischemia in white rats. The animals were divided into two groups: the control group receiving no treatment and the experimental group, to which the Т0АМ thyronamine synthetic analogue was intraperitoneally administrated (75 mg/kg of the rat’s body weight). After 24 h the rat was decapitated, and the cerebral cortex tissue was extracted for biochemical analysis. The following LP indicators were determined by spectrophotometry: malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GPx). When administering the Т0АМ thyronamine synthetic analogue, a significant (2-fold) decrease in MDA levels was observed in the ischemic hemisphere (р = 0.022), along with the 2.49-fold increase in the GPx activity in the brain tissue (р = 0.004) of the intact hemisphere and the 2.65-fold increase in its activity (р = 0.021) in the ischemic hemisphere, as well as the 1.23-fold increase in SOD activity in the ischemic hemisphere (р = 0.042). The Т0АМ thyronamine synthetic analogue has a great potential in terms of activation of the antioxidant protection mechanisms in the cerebral cortex of white laboratory rats under conditions of acute hemispheric ischemia.

Keywords: lipid peroxidation, ischemic stroke, antioxidants, oxidative stress, thyronamines, neuroprotection

КОММЕНТАРИИ (0)